Effects of crystalline form on the tableting compression mechanism of phenobarbital polymorphs

Drug Development and Industrial Pharmacy

Volumn 25, Issue 2, 1999, Pages 205-215

  Otsuka, M ^a   Nakanishi, M ^a   Matsuda, Y ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL;

ARTICLE; CRYSTAL STRUCTURE; HARDNESS; MATHEMATICAL ANALYSIS; POROSITY; TABLET COMPRESSION; TABLET FORMULATION; X RAY DIFFRACTION;

ANTICONVULSANTS; CHEMISTRY, PHYSICAL; CRYSTALLIZATION; DOSAGE FORMS; DRUG COMPOUNDING; EXCIPIENTS; HARDNESS; NONLINEAR DYNAMICS; PHENOBARBITAL; PRESSURE; REGRESSION ANALYSIS; TABLETS; X-RAY DIFFRACTION;

EID: 0033005242     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100102161     Document Type: Article

References (29)

1. C. F. Lerk, A. C. Andrease, A. H. De Boer, G. K. Bolhuis, K. Zuuramn, P. De Hoog, K, Kussendrager, and J. Van Leverink, J. Pharm. Pharmacol., 35, 747-748 (1983).
2. M. Otsuka, N. Kaneniwa, K. Otsuka, K. Kawakami, O. Umezawa, and Y. Matsuda, J. Pharm. Sci., 81, 1189-1193 (1992).
3. M. Otsuka and Y. Matsuda, in Encyclopedia of Pharmaceutical Technology, Vol. 12 (J. Swarbrick and J. C. Boylan, eds.), Marcel Dekker, New York, 1995, pp. 305-326.
4. G. Alderborn, Pasanen, and C. Nyrstom, Int. J. Pharm., 23,79-86 (1985).
5. J. R. Britten and N. Pilpel, J. Pharm. Pharmacol., 30, 673-677 (1978).
6. H. K. Chan and E. Doelker, Drug Dev. Ind. Phar., 11, 315-332 (1985).
7. M. Duberg and C. Nystrom, Acta Pharm. Suec., 19, 421-436 (1982).
8. M. Duberg and C. Nystrom, Powder Technol., 46, 67-75 (1986).
9. J. T. Fell and J. M. Newton, J. Pharm. Sci., 60, 1866-1869 (1971).
10. J. S. Hardman and B. A. Lilley, Nature, 228, 353-355 (1970).
11. J. A. Hersey, J. E. Rees, and E. T. Cole, J. Pharm. Sci., 62, 2060 (1973).
12. J. A. Hersey, G. Bayraktar, and E. Shotton, J. Pharm. Pharmacol., 19, 24s-30s (1967).
13. P. Humbert-Droz, D. Mordier, and E. Doelker, Pharm. Acta Helve., 57, 136-143 (1982).
14. G. Ibrahim, F. Pisano, and A. Bruno, J. Pharm. Sci., 66, 669-673 (1977).
15. M. Otsuka, T. Matsumoto, and N. Kaneniwa, J. Pharm. Pharmacol., 41, 665-669 (1989).
16. M. Otsuka, T. Matsumoto, S. Higuchi, K. Otsuka, and N. Kaneniwa, J. Pharm. Sci., 84, 614-618 (1995).
17. A. R. Cooper and L. E. Eaton, J. Am. Ceram. Soc., 45, 97-101 (1962).
18. R. W. Heckel, Trans. Metall. Soc. AIME, 221, 671-675 (1961).
19. R. W. Heckel, Trans. Metall. Soc. AIME, 221, 1001-1008 (1961).
20. T. Y. Huang, Acta Pharm. Intern., 2, 43-68 (1951).
21. B. Cleverley and P. P. Williams, Tetrahedron, 7, 277-288 (1959).
22. R. J. Mesley, R. L. Clements, B. Flaherty, and K. Goodhead, J. Pharm. Pharmacol., 20, 329-340 (1968).
23. H. M. El-Banna, A. R. Ebian, and A. A. Isomail, Pharmazie, 30, 455-460 (1975).
24. O. I. Corrigan, K. Sabra, and E. M. Holohan, Drug Dev. Ind. Pharm., 9, 1-20 (1983).
25. H. Nogami, T. Nagai, and T. Yotsuyanagi, Chem. Pharm. Bull., 17, 499-509 (1969).
26. K. Kato and F. Watanabe, Yakugaku Zasshi, 98, 639-648 (1978).
27. M. Otsuka, M. Onoe, and Y. Matsuda, Pharm. Res., 10, 577-582 (1993).
28. S. Kopp, C. Beyer, E. Graf, F. Kubel, and E. Delker, J. Pharm. Pharmcol., 41, 79-82 (1988).
29. K. Yamaoka, T. Tanigawara, T. Nakagawa, and T. Uno, J. Pharmacbio-Dyn., 4, 879-885 (1981).